Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 929
Guide Official Revision Description Reason for Update
Version Date Number Of Change
criteria for deferment to
AMCD or Region.
2009 09/21/2009 3. Medical Policy In Aerospace Medical
Dispositions, Item 48.
General Systemic, Diabetes
– change title to “Diabetes,
Metabolic Syndrome, and/or
Insulin Resistance.” Also
add new table entry to reflect
criteria for “Metabolic
Syndrome or Insulin
Resistance.”
2009 09/21/2009 4. Medical Policy In AME Assisted Special
Issuance, All Classes –
added entry and criteria for
Metabolic Syndrome
(Glucose Intolerance,
Impaired Glucose Tolerance,
Impaired Fasting Glucose,
Insulin Resistance, and Pre-
Diabetes). Also added entry
on AASI Certificate Issuance
sheet.
2009 09/21/2009 5. Administrative In General Information, Who
May Be Certified, b.
Language Requirements –
added information to clarify
guidance on certification and
reporting process.
2009 07/30/2009 1. Medical Policy In Pharmaceuticals, Acne
Medications, add language
to further clarify instructions
for deferral and restrictions.
2009 07/09/2009 1. Medical Policy In Pharmaceuticals,
Diabetes Mellitus – Type II,
Medication Controlled, revise
to remove amlynomimetics
from allowable combinations.
2009 07/09/2009 2. Medical Policy In AASI, Diabetes Mellitus –
Type II, Medication
Controlled, revise criteria for
deferring to AMCD or region.
2009 05/13/2009 1. Medical Policy In General Information,
Equipment Requirements
and Examination Equipment
and Techniques, Item 52.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
